Once weekly recombinant human erythropoietin treatment for cancer-induced anemia in children with acute lymphoblastic leukemia receiving maintenance chemotherapy: a randomized case-controlled study. (terbuka di window baru)

Abdelrazik N, Fouda M

Sumber‎: Hematology 2007;12(6):533-41.

Index‎: PubMed 17852440

DOI‎: 10.1080/10245330701521572

https://www.ncbi.nlm.nih.gov/pubmed/17852440 (terbuka di window baru)

Epoetin alpha decreases the number of erythrocyte transfusions in patients with acute lymphoblastic leukemia, lymphoblastic lymphoma, and Burkitt leukemia/lymphoma: results of a randomized clinical trial. (terbuka di window baru)

Cabanillas ME, Kantarjian H, Thomas DA, Mattiuzzi GN, Rytting ME, Bruera E, Xiao L, Bekele BN, Foudray MC, Cortes JE.

Sumber‎: Cancer 2012;118(3):848-55.

Index‎: PubMed 21751205

DOI‎: 10.1002/cncr.26341

https://www.ncbi.nlm.nih.gov/pubmed/21751205 (terbuka di window baru)

Recombinant human erythropoietin beta therapy: an effective strategy to reduce transfusion requirement in children receiving anticancer treatment. (terbuka di window baru)

Corapcioglu F, Aksu G, Basar EZ, Demirel A, Oncel S, Mutlu A

Sumber‎: Pediatr Hematol Oncol 2008;25(6):509-21.

Index‎: PubMed 18728970

DOI‎: 10.1080/08880010802235132

https://www.ncbi.nlm.nih.gov/pubmed/18728970 (terbuka di window baru)

Recombinant human erythropoietin beta: the effect of weekly dosing on anemia, quality of life, and long-term outcomes in pediatric cancer patients. (terbuka di window baru)

Durmaz O, Demirkaya M, Sevinir B

Sumber‎: Pediatr Hematol Oncol 2011;28(6):461-8.

Index‎: PubMed 21707225

DOI‎: 10.3109/08880018.2011.570857

https://www.ncbi.nlm.nih.gov/pubmed/21707225 (terbuka di window baru)

Epoetin alfa in patients with advanced-stage Hodgkin's lymphoma: results of the randomized placebo-controlled GHSG HD15EPO trial. (terbuka di window baru)

Engert A, Josting A, Haverkamp H, Villalobos M, Lohri A, Sökler M, Zijlstra J, Sturm I, Topp MS, Rank A, Zenz T, Vogelhuber M, Nogova L, Borchmann P, Fuchs M, Flechtner HH, Diehl V.

Sumber‎: J Clin Oncol 2010;28(13):2239-45.

Index‎: PubMed 20368566

DOI‎: 10.1200/JCO.2009.25.1835

https://www.ncbi.nlm.nih.gov/pubmed/20368566 (terbuka di window baru)

Treatment patterns and outcomes in management of solid cancer patients suffering from anemia in Penang hospital. (terbuka di window baru)

Hassan BA, Yusoff ZB

Sumber‎: Asian Pac J Cancer Prev 2011;12(6):1573-6.

Index‎: PubMed 22126501

https://www.ncbi.nlm.nih.gov/pubmed/22126501 (terbuka di window baru)

Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced anemia. (terbuka di window baru)

Hernandez E, Ganly P, Charu V, Dibenedetto J, Tomita D, Lillie T, Taylor K; ARANESP 20030232 Study Group

Sumber‎: Curr Med Res Opin 2009;25(9):2109-20.

Index‎: PubMed 19601709

DOI‎: 10.1185/03007990903084164

https://www.ncbi.nlm.nih.gov/pubmed/19601709 (terbuka di window baru)

Hemoglobin response and improvements in quality of life in anemic children with cancer receiving myelosuppressive chemotherapy. (terbuka di window baru)

Hinds PS, Hockenberry M, Feusner J, Hord JD, Rackoff W, Rozzouk BI

Sumber‎: J Support Oncol 2005;3(6 Suppl 4):10-1.

Index‎: PubMed 16355549

https://www.ncbi.nlm.nih.gov/pubmed/16355549 (terbuka di window baru)

The efficacy of recombinant human erythropoietin in treatment chemotherapy induced anemia in children diagnosed with a solid cancer. (terbuka di window baru)

Hiradfar A, Banihosseinian M

Sumber‎: Iran J Ped Hematol Oncol 2014;4(4):151-9.

Index‎: PubMed 25598955

https://www.ncbi.nlm.nih.gov/pubmed/25598955 (terbuka di window baru)

2007 Standards, Options, and Recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbepoetin) for the management of anemia in children with cancer. (terbuka di window baru)

Marec-Berard P, Chastagner P, Kassab-Chahmi D, Casadevall N, Marchal C, Misset JL, Ray-Coquard I.

Sumber‎: Pediatr Blood Cancer 2009;53(1):7-12.

Index‎: PubMed 19229970

DOI‎: 10.1002/pbc.21953

https://www.ncbi.nlm.nih.gov/pubmed/19229970 (terbuka di window baru)

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients. (terbuka di window baru)

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Sumber‎: Cancer 2013;119(1):107-14.

Index‎: PubMed 22744794

DOI‎: 10.1002/cncr.27686

https://www.ncbi.nlm.nih.gov/pubmed/22744794 (terbuka di window baru)

Erythropoietic growth factors for children with cancer: a systematic review of the literature. (terbuka di window baru)

Mystakidou K, Potamianou A, Tsilika E

Sumber‎: Curr Med Res Opin 2007;23(11):2841-7.

Index‎: PubMed 17910805

DOI‎: 10.1185/030079907x242601

https://www.ncbi.nlm.nih.gov/pubmed/17910805 (terbuka di window baru)

Double-blind, placebo-controlled study of quality of life, hematologic end points, and safety of weekly epoetin alfa in children with cancer receiving myelosuppressive chemotherapy. (terbuka di window baru)

Razzouk BI, Hord JD, Hockenberry M, Hinds PS, Feusner J, Williams D, Rackoff WR

Sumber‎: J Clin Oncol 2006;24(22):3583-9.

Index‎: PubMed 16877725

DOI‎: 10.1200/JCO.2005.03.4371

https://www.ncbi.nlm.nih.gov/pubmed/16877725 (terbuka di window baru)

The role of recombinant erythropoietin in childhood cancer. (terbuka di window baru)

Shankar AG

Sumber‎: Oncologist 2008;13(2):157-66.

Index‎: PubMed 18305061

DOI‎: 10.1634/theoncologist.2007-0126

https://www.ncbi.nlm.nih.gov/pubmed/18305061 (terbuka di window baru)

Efficacy and safety of iorEPOCIM for chemotherapy- or radiotherapy-induced anemia in pediatric cancer patients. (terbuka di window baru)

Vargas A, Mendoza I, Uranga R, González A, Martínez L, Caballero I, Piedra P, Saurez G, Verdecia M, Cabanas R

Sumber‎: MEDICC Rev 2010;12(3):27-31.

Index‎: PubMed 20697335

DOI‎: 10.37757/MR2010.V12.N3.7

https://www.ncbi.nlm.nih.gov/pubmed/20697335 (terbuka di window baru)

A single institutional experience: is epoetin alpha effective in anemic children with cancer? (terbuka di window baru)

Yilmaz D, Cetingül N, Kantar M, Oniz H, Kansoy S, Kavakli K

Sumber‎: Pediatr Hematol Oncol 2004;21(1):1-8.

Index‎: PubMed 14660300

https://www.ncbi.nlm.nih.gov/pubmed/14660300 (terbuka di window baru)

Single dose darbepoetin alfa is useful in reducing red cell transfusions in leukemic children receiving chemotherapy. (terbuka di window baru)

Zachariah M, Elshinawy M, Alrawas A, Bashir W, Elbeshlawi I, Tony S, Wali Y

Sumber‎: Pediatr Hematol Oncol 2014;31(5):442-7.

Index‎: PubMed 24088186

DOI‎: 10.3109/08880018.2013.824527

https://www.ncbi.nlm.nih.gov/pubmed/24088186 (terbuka di window baru)

Early epoetin alfa treatment in children with solid tumors. (terbuka di window baru)

Zoubek A, Kronberger M

Sumber‎: Med Pediatr Oncol 2002;39(4):459-62.

Index‎: PubMed 12203664

DOI‎: 10.1002/mpo.10186

https://www.ncbi.nlm.nih.gov/pubmed/12203664 (terbuka di window baru)

Intravenous iron sucrose for children with iron deficiency failing to respond to oral iron therapy. (terbuka di window baru)

Crary SE, Hall K, Buchanan GR.

Sumber‎: Pediatr Blood Cancer 2011;56(4):615-9.

Index‎: PubMed 21298748

DOI‎: 10.1002/pbc.22930

https://www.ncbi.nlm.nih.gov/pubmed/21298748 (terbuka di window baru)

Intravenous iron sucrose for children with iron deficiency anemia. (terbuka di window baru)

Kaneva K, Chow E, Rosenfield CG, Kelly MJ

Sumber‎: J Pediatr Hematol Oncol 2017;39(5):e259-62.

Index‎: PubMed 28562517

DOI‎: 10.1097/MPH.0000000000000879

https://www.ncbi.nlm.nih.gov/pubmed/28562517 (terbuka di window baru)

Advances in Pediatric Intravenous Iron Therapy. (terbuka di window baru)

Mantadakis E.

Sumber‎: Pediatr Blood Cancer 2016;63(1):11-6.

Index‎: PubMed 26376214

DOI‎: 10.1002/pbc.25752

https://www.ncbi.nlm.nih.gov/pubmed/26376214 (terbuka di window baru)

The role of iron in the management of chemotherapy-induced anemia in cancer patients receiving erythropoiesis-stimulating agents. (terbuka di window baru)

Mhaskar R, Wao H, Miladinovic B, Kumar A, Djulbegovic B.

Sumber‎: Cochrane Database Syst Rev 2016;(2):CD009624.

Index‎: PubMed 26845108

DOI‎: 10.1002/14651858.CD009624.pub2

https://www.ncbi.nlm.nih.gov/pubmed/26845108 (terbuka di window baru)

Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha. (terbuka di window baru)

Pedrazzoli P, Farris A, Del Prete S, Del Gaizo F, Ferrari D, Bianchessi C, Colucci G, Desogus A, Gamucci T, Pappalardo A, Fornarini G, Pozzi P, Fabi A, Labianca R, Di Costanzo F, Secondino S, Crucitta E, Apolloni F, Del Santo A, Siena S.

Sumber‎: J Clin Oncol 2008;26(10):1619-25.

Index‎: PubMed 18375891

DOI‎: 10.1200/JCO.2007.12.2051

https://www.ncbi.nlm.nih.gov/pubmed/18375891 (terbuka di window baru)

Intravenous low molecular weight iron dextran in children with iron deficiency anemia unresponsive to oral iron. (terbuka di window baru)

Plummer ES, Crary SE, McCavit TL, Buchanan GR

Sumber‎: Pediatr Blood Cancer 2013;60(11):1747-52.

Index‎: PubMed 23832487

DOI‎: 10.1002/pbc.24676

https://www.ncbi.nlm.nih.gov/pubmed/23832487 (terbuka di window baru)